Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder	Recruiting	Phase 2	2025-12-08		NCT06091124

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
RenJi Hospital	264

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Jiangsu Province Hospital	Nanjing	China	37
Renji Hospital	Shanghai	China	16
The First Affiliated Hospital of Xi'an Jiao Tong University	Xi'an	China	6
The Second Hospital of Tianjin Medical University	Tianjin	China	7
West China Hospital	Chengdu	China	21